Pediatric Radiation Retinopathy: Impact of Early Diagnosis and Targeted Treatment
This study offers new medical evidence suggesting that early diagnosis and antivascular endothelial growth factor therapy may improve visual outcomes in pediatric radiation retinopathy. Intravitreal bevacizumab improved visual acuity and anatomy in pediatric eyes with stable retinoblastoma and radiation maculopathy.
Authors
- Aaron S. Gold (ORCID: https://orcid.org/0000-0003-3017-2527)
- Víctor M. Villegas (ORCID: https://orcid.org/0000-0002-1002-2647)
- Sophia El Hamichi (ORCID: https://orcid.org/0000-0002-9966-0556)
- Azeema Latiff
- Andrea Rosado
- Audina M. Berrocal
- Timothy G. Murray
Institutions
- University of Miami (US)
- University of Puerto Rico, Medical Sciences Campus (PR)
- Ponce Health Sciences University (PR)
Publication Details
- Journal
- Journal of VitreoRetinal Diseases
- Published
- 2026-04-15
- DOI
- https://doi.org/10.1177/24741264261438443
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00